Altamira Therapeutics Ltd (NASDAQ:CYTO) shares, rose in value, with the stock price down by -8.86% to the previous day’s close as strong demand from buyers drove the stock to $1.44. Actively observing the price movement in the last trading, the stock closed the session at
Altamira Therapeutics Ltd (NASDAQ:CYTO) price is hovering lower on Tuesday, March 26, dropping -6.38% below its previous close. A look at today’s price movement shows that the recent level at last check reads $2.35. The company’s 5Y monthly beta was ticking 2.49. Taking into account
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
